STERIALS

A biopharmaceutical company engaged in the research, development, and commercialization of drugs for the treatment of central nervous system disorders. The company sells products effective in treating epilepsy, attention deficit hyperactivity disorder, and motor impairment caused by Parkinson's disease, as well as preventing migraines. It is also developing potential treatments for treatment-resistant depression and other conditions. The company is based in Delaware.